Fauci: Vaccine efficacy, availability key to COVID-19 fight | Infectious disease leaders call for mask mandate | Cigna, Kaiser back mental health startup Ginger
August 6, 2020
A news roundup for health care executivesSIGN UP ⋅   SHARE
Top Story
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has expressed cautious optimism for the speed at which COVID-19 vaccines are being developed. "Historically, if you get a vaccine that has a moderate to high degree of efficacy, and you combine with that prudent public health measures, we can put this behind us," Fauci said.
Full Story: Reuters (8/5) 
LinkedIn Twitter Facebook Email
It’s All About Function!
Naked Prosthetics designs and fabricates durable, custom prosthetic devices specifically for finger loss. Our mission is to assist people with full to partial digit amputation(s) and to positively impact their lives by providing functional, high-quality finger prostheses. Learn more.
Health Care Leadership & Innovation
The Infectious Diseases Society of America and the HIV Medicine Association are calling for a national strategy on masks and a federal mandate for mask wearing to fight COVID-19. They sent a letter to Vice President Mike Pence that said there is a "critical window of time" to reduce the spread of COVID-19 before the influenza season begins and hospitals likely become overwhelmed.
Full Story: Forbes (8/5) 
LinkedIn Twitter Facebook Email
Cigna Ventures and Kaiser Permanente Ventures are among the latest investors to back San Francisco-based startup Ginger, which landed $50 million more in funding to expand its on-demand mental health care services. The company has experienced record demand for services during the novel coronavirus pandemic, and CEO Russell Glass said people want better care and big health care payers are recognizing the need to respond.
Full Story: FierceHealthcare (8/6) 
LinkedIn Twitter Facebook Email
One platform. One partner. One purpose.
The Sunrise single patient record helps organizations improve patient outcomes, while driving operational and financial efficiencies. In times of crisis and beyond, Allscripts helps deliver smarter, more connected care that is alive with possibilities. Learn more.
Legislation, Policy & Regulation
President Donald Trump is expected to sign an executive order today that would require the US government to purchase essential drugs from US companies instead of foreign countries. White House trade advisor Peter Navarro said the order also would remove some pharmaceutical manufacturing regulations and fast-track the review process for making some drug ingredients.
Full Story: CNBC (8/6) 
LinkedIn Twitter Facebook Email
The FDA has developed regulations that allow pharmaceutical companies to use advanced manufacturing techniques to expedite production of COVID-19 treatments and vaccines, according to Commissioner Stephan Hahn and Deputy Commissioner for Medical and Scientific Affairs Anand Shah. The regulations focus on using new technology in public health emergencies, examining technical concerns when manufacturing gene therapies and helping companies develop control processes for continuous manufacturing before drugs are submitted for approval.
Full Story: Regulatory Focus (8/4) 
LinkedIn Twitter Facebook Email
Featured Content
Sponsored content from 1440 Media
Tired of being told how to think? Meet 1440Check out 1440 – The fastest way to an impartial point-of-view. The team at 1440 scours over 100+ sources so you don't have to. Culture, science, sports, politics, business and everything in between - in a 5-minute read each morning, 100% free. Sign up now!

    Trends & Technology
    Telehealth company Teladoc Health will buy Livongo Health, which offers remote health coaching and monitoring, for $18.5 billion if shareholders and regulators approve the deal. Livongo has expanded from diabetes management into other disease areas, including hypertension, and makes its own monitoring equipment instead of relying on other manufacturers.
    Full Story: STAT (tiered subscription model) (8/5) 
    LinkedIn Twitter Facebook Email
    Artificial intelligence can be used as a framework to improve pharmaceutical processes from the lab to clinical trials by focusing on automated, assistive, analytical, accelerated and augmented intelligence, writes Andrew Satz, a data scientist and CEO and cofounder of EVQLV. Companies that follow this thinking can use AI in practical ways to improve a variety of outcomes, he adds.
    Full Story: Life Science Leader (8/3) 
    LinkedIn Twitter Facebook Email
    The number of physicians affiliated with a health care system increased from 40% to 51% from 2016 to 2018, researchers reported in Health Affairs. Among primary care physicians the increase was from 38% to 49%.
    Full Story: Medscape (free registration) (8/5) 
    LinkedIn Twitter Facebook Email
    Sharing SmartBrief for Health Care Leaders with your network keeps the quality of content high and these newsletters free.
    SmartBrief will donate $10 per new reader to organizations fighting for climate reform, women's rights, global health initiatives and more.
    Or copy and share your personalized link:
    I am awaiting perpetually and forever a renaissance of wonder
    Lawrence Ferlinghetti,
    LinkedIn Twitter Facebook Email
    SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio
    Sign Up  |    Update Profile  |    Advertise with SmartBrief
    Unsubscribe  |    Privacy policy
    SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004